ES2046300T3 - Composicion para el tratamiento de la piel. - Google Patents
Composicion para el tratamiento de la piel.Info
- Publication number
- ES2046300T3 ES2046300T3 ES198888305255T ES88305255T ES2046300T3 ES 2046300 T3 ES2046300 T3 ES 2046300T3 ES 198888305255 T ES198888305255 T ES 198888305255T ES 88305255 T ES88305255 T ES 88305255T ES 2046300 T3 ES2046300 T3 ES 2046300T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- fragments
- topical application
- hyaluronic acid
- skin treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012634 fragment Substances 0.000 abstract 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 2
- 125000001483 monosaccharide substituent group Chemical group 0.000 abstract 2
- 230000000699 topical effect Effects 0.000 abstract 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical group OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
- 230000002491 angiogenic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000003779 hair growth Effects 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878713747A GB8713747D0 (en) | 1987-06-12 | 1987-06-12 | Skin treatment composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2046300T3 true ES2046300T3 (es) | 1994-02-01 |
Family
ID=10618796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198888305255T Expired - Lifetime ES2046300T3 (es) | 1987-06-12 | 1988-06-09 | Composicion para el tratamiento de la piel. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0295092B1 (enExample) |
| JP (1) | JPH078770B2 (enExample) |
| AT (1) | ATE80790T1 (enExample) |
| AU (1) | AU613920B2 (enExample) |
| BR (1) | BR8802863A (enExample) |
| CA (1) | CA1318252C (enExample) |
| DE (1) | DE3874813T2 (enExample) |
| ES (1) | ES2046300T3 (enExample) |
| GB (1) | GB8713747D0 (enExample) |
| GR (1) | GR3006096T3 (enExample) |
| IN (1) | IN167137B (enExample) |
| PH (1) | PH25084A (enExample) |
| ZA (1) | ZA884172B (enExample) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618798A (en) * | 1989-04-20 | 1997-04-08 | Bar-Shalom; Daniel | Use of sucralfate to treat baldness |
| DK191889D0 (da) * | 1989-04-20 | 1989-04-20 | Bukh Meditec | Kosmetisk middel |
| CA2016351C (en) * | 1989-05-12 | 1996-09-03 | Walter Thomas Gibson | Cosmetic composition |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5639738A (en) * | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| JPH05506040A (ja) * | 1991-02-14 | 1993-09-02 | バクスター、インターナショナル、インコーポレイテッド | 生体接着性リポソームと標的部位との相互作用 |
| WO1994007505A1 (en) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5990095A (en) * | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
| US5792753A (en) * | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
| US6022866A (en) * | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5817644A (en) * | 1991-07-03 | 1998-10-06 | Hyal Pharmaceutical Corporation | Targeting of dosages of medicine and therapeutic agents |
| CA2061567C (en) * | 1992-02-20 | 1998-02-03 | Rudolf E. Falk | Use of hyaluronic acid to repair ischemia reperfusion damage |
| US6136793A (en) * | 1992-02-20 | 2000-10-24 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US6114314A (en) * | 1992-02-21 | 2000-09-05 | Hyal Pharmaceutical Corp. | Formulations containing hyaluronic acid |
| GB2266239B (en) * | 1992-03-25 | 1996-03-06 | Jevco Ltd | Wound healing compositions containing chondroitin sulphate oligosaccharides |
| CA2165826A1 (en) * | 1993-07-01 | 1995-01-12 | Alain E. Lagarde | Hyaluronic acid fragments and their therapeutic use |
| IT1282219B1 (it) * | 1995-12-20 | 1998-03-16 | Fidia Advanced Biopolymers Srl | Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa |
| US5908867A (en) * | 1996-07-18 | 1999-06-01 | Henry; James P. | Reduction of hair growth |
| US6123957A (en) * | 1997-07-16 | 2000-09-26 | Jernberg; Gary R. | Delivery of agents and method for regeneration of periodontal tissues |
| CA2330388A1 (en) | 1998-04-30 | 1999-11-11 | Maruha Corporation | Compounds having glucuronic acid derivative and glucosamine derivative in structure thereof, method for producing the compounds, and uses of the compounds |
| DE19843566A1 (de) * | 1998-09-23 | 2000-03-30 | Beiersdorf Ag | Verwendung von Wirkstoffen, gewählt aus der Gruppe der 1,2-Diacylglycerole, zur Stärkung der Barrierefunktion der Haut |
| DE59906391D1 (de) * | 1998-12-23 | 2003-08-28 | Esparma Gmbh | Mittel zum schutz der haut enthaltend hydrolysierte hyaluronsäure |
| CZ20013174A3 (cs) | 1999-03-05 | 2002-02-13 | The Procter & Gamble Company | C16 nenasycené FP-selektivní prostaglandinové analogy |
| FR2792319B1 (fr) * | 1999-04-14 | 2001-07-06 | Pf Medicament | Procede de preparation de monosulfate de 4 ou 6 disaccharides, leur utilisation en cosmetique et en tant que medicament notamment pour le traitement des maladies du collagene |
| FR2793140B1 (fr) * | 1999-05-03 | 2003-01-24 | Lafon Labor | Utilisation de fragments d'acide hyaluronique |
| JP4450456B2 (ja) | 1999-09-27 | 2010-04-14 | 株式会社マルハニチロ水産 | 皮脂産生抑制剤 |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| FR2818547B1 (fr) | 2000-12-22 | 2006-11-17 | Oreal | Nouveaux derives c-glycosides et utilisation |
| DE10111165A1 (de) * | 2001-03-02 | 2002-10-10 | Knoell Hans Forschung Ev | Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen |
| US7099713B2 (en) | 2002-06-28 | 2006-08-29 | Battelle Memorial Institute | Skin conduction and transport systems |
| ITMI20050262A1 (it) * | 2005-02-21 | 2006-08-22 | Carlo Ghisalberti | Sostanze composizioni e metodi di trattamento dell'alopecia |
| US20060237021A1 (en) * | 2005-04-21 | 2006-10-26 | Guay Gordon G | Methods and devices for rejuvenating skin |
| ITPD20050146A1 (it) * | 2005-05-20 | 2006-11-21 | Fidia Farmaceutici | Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati |
| US8758819B2 (en) | 2006-09-13 | 2014-06-24 | Enhance Skin Products, Inc. | Cosmetic compositions for the treatment of skin and methods thereof |
| US8529951B1 (en) | 2007-02-21 | 2013-09-10 | Anand Ramamurthi | Elastogenic cues and methods for using same |
| WO2008129607A1 (ja) * | 2007-04-06 | 2008-10-30 | Glycoscience Laboratories, Inc. | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 |
| CA2686556A1 (fr) * | 2007-05-11 | 2008-12-11 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
| ITMI20072348A1 (it) * | 2007-12-17 | 2009-06-18 | Medichem Srl | Metodo per la rigenerazione cellulare di acido ialuronico e relativa composizione cosmetica |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| BE1018697A3 (fr) * | 2009-03-16 | 2011-07-05 | Auriga Internat | Composition cosmetique a application topique comprenant de l'acide hyaluronique. |
| US9389380B2 (en) | 2011-05-31 | 2016-07-12 | Konica Minolta, Inc. | Optical fiber assembly, optical probe, and method for manufacturing optical fiber assembly |
| SG11201404959TA (en) * | 2012-02-22 | 2014-11-27 | Hyaluronan Res Inst Inc | Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active agent |
| JP2014080374A (ja) * | 2012-10-12 | 2014-05-08 | Yoshihiro Tokutome | イオントフォレーシス用組成物 |
| GR1008308B (el) | 2013-05-31 | 2014-10-02 | UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", | Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα |
| WO2019075263A2 (en) * | 2017-10-11 | 2019-04-18 | Illustris Pharmaceuticals, Inc. | METHODS AND COMPOSITIONS WITH TOPICAL ADMINISTRATION |
| JP7374687B2 (ja) * | 2019-09-26 | 2023-11-07 | 三和酒類株式会社 | ペンタペプチド化合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1283892A (en) * | 1970-06-08 | 1972-08-02 | Irwin Irville Lubowe | Improvements in and relating to medicinal compositions for application to the skin and/or hair |
| US4303676A (en) * | 1980-03-21 | 1981-12-01 | Balazs Endre A | Hyaluronate based compositions and cosmetic formulations containing same |
| IT1177276B (it) * | 1984-11-20 | 1987-08-26 | Farmaka Srl | Composizioni cosmetiche dermotrope |
| US4879114A (en) * | 1985-12-20 | 1989-11-07 | Angio-Medical Corporation | Lipids from omentum and methods for cosmetic use |
| FR2591889B1 (fr) * | 1985-12-24 | 1988-12-09 | Roussel Uclaf | Nouveau shampooing a base d'un ou de plusieurs tensio-actifs non ioniques et de mucopolysaccharides |
| JPS62292710A (ja) * | 1986-06-12 | 1987-12-19 | Lion Corp | 皮膚化粧料 |
| JPS63150210A (ja) * | 1986-12-15 | 1988-06-22 | Kanebo Ltd | 養毛化粧料 |
| US4767463A (en) * | 1987-04-15 | 1988-08-30 | Union Carbide Corporation | Glycosaminoglycan and cationic polymer combinations |
| JP2549119B2 (ja) * | 1987-05-30 | 1996-10-30 | 三省製薬株式会社 | 外用剤 |
-
1987
- 1987-06-12 GB GB878713747A patent/GB8713747D0/en active Pending
-
1988
- 1988-06-07 CA CA000569286A patent/CA1318252C/en not_active Expired - Fee Related
- 1988-06-07 AU AU17459/88A patent/AU613920B2/en not_active Ceased
- 1988-06-09 DE DE8888305255T patent/DE3874813T2/de not_active Expired - Fee Related
- 1988-06-09 AT AT88305255T patent/ATE80790T1/de active
- 1988-06-09 EP EP19880305255 patent/EP0295092B1/en not_active Expired - Lifetime
- 1988-06-09 ES ES198888305255T patent/ES2046300T3/es not_active Expired - Lifetime
- 1988-06-09 IN IN166/BOM/88A patent/IN167137B/en unknown
- 1988-06-10 BR BR8802863A patent/BR8802863A/pt not_active Application Discontinuation
- 1988-06-10 ZA ZA884172A patent/ZA884172B/xx unknown
- 1988-06-10 PH PH37045A patent/PH25084A/en unknown
- 1988-06-10 JP JP63143448A patent/JPH078770B2/ja not_active Expired - Lifetime
-
1992
- 1992-10-27 GR GR920402425T patent/GR3006096T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0295092B1 (en) | 1992-09-23 |
| DE3874813T2 (de) | 1993-03-11 |
| AU613920B2 (en) | 1991-08-15 |
| IN167137B (enExample) | 1990-09-01 |
| JPS6413008A (en) | 1989-01-17 |
| BR8802863A (pt) | 1989-01-03 |
| ATE80790T1 (de) | 1992-10-15 |
| CA1318252C (en) | 1993-05-25 |
| ZA884172B (en) | 1990-02-28 |
| GR3006096T3 (enExample) | 1993-06-21 |
| AU1745988A (en) | 1988-12-15 |
| EP0295092A3 (en) | 1990-09-05 |
| PH25084A (en) | 1991-02-19 |
| GB8713747D0 (en) | 1987-07-15 |
| DE3874813D1 (de) | 1992-10-29 |
| EP0295092A2 (en) | 1988-12-14 |
| JPH078770B2 (ja) | 1995-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2046300T3 (es) | Composicion para el tratamiento de la piel. | |
| US5091171B1 (en) | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | |
| ES2148504T3 (es) | Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2. | |
| ATE299012T1 (de) | Kosmetische zusammensetzung fuer hautregenerierung ohne hautreizung | |
| BR9403783A (pt) | Uso de uma composição cosmética | |
| AU2789989A (en) | Acylated uridine and cytidine and uses thereof | |
| MY110734A (en) | Improvements in or relating to dioic acids. | |
| ITMI911423A1 (it) | Lamina di collageno non poroso per uso terapeutico, metodo ed apparecchiature per ottenerlo | |
| ES2018015B3 (es) | Composicion para tratamiento de la piel. | |
| DE60124715D1 (de) | Er produktion von beta-endorphin | |
| ES2056206T3 (es) | Derivados lactamicos de carbohidratos y su empleo en composiciones cosmeticas. | |
| BR9402089A (pt) | Composição para cuidado da pele e processo para melhorar as propriedades de irritação provocada por retinol | |
| AU5283890A (en) | Fibroblast growth factor (fgf)-based stabilized compositions | |
| KR970009581B1 (en) | Composition for topical use containing depolymerized deoxyribonucleic acids in the skin and body cosmetic treathent | |
| EP0957107A4 (enExample) | ||
| ZA895840B (en) | N-2,3-butadienyl tri-and tetraaminoalkane derivatives | |
| DE69600056D1 (de) | Mittel zur dauerhaften Haarverformung | |
| ZA903579B (en) | Cosmetic composition | |
| GB8911208D0 (en) | Cosmetic composition | |
| TH5628A (th) | ส่วนประกอบสารรักษาผิว | |
| HUT50279A (en) | Skin treating cosmetic comprising apple pectine and process for preparation thereof | |
| RU97114944A (ru) | Лечение диабетической невропатии | |
| MX20B (es) | Mejoras en agujas utilizadas en electropuntura o galvanopuntura |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 295092 Country of ref document: ES |